| Name | Title | Contact Details |
|---|
J & D Laboratories is a Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Coventry Health Care, Inc. (Coventry) is a diversified national insurer in the United States. Based in Bethesda, Maryland, Coventry operates health plans, insurance companies, network rental and workers’ compensation services companies. Coventry provides a full range of risk and fee-based managed care products and services to a broad cross section of individuals, employer and government-funded groups, government agencies, and other insurance carriers and administrators. It is currently ranked the third most successful prescription drug plan service in the United States.
Aids Project New Haven is a New Haven, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
L-Nutra is a nutri-technology company dedicated to helping people increase their healthspan (healthy years of their lives) through fasting and nutrition with the launch of our first product The Fasting Mimicking Diet.